Fin Cascade

Prices as of 8 Oct 2026 close · Not investment advice

Colgate-Palmolive India

NSE: COLPALPersonal Care

Share price

₹1,735.70

-1.23% close of 8 Oct 2026

Market cap ₹46,864 CrP/E 34.8

Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 6 Oct 2026, the close above is 8 Oct 2026.

Business score

How strong the business is, in one number. The parts behind it are in Pro.

69

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹46,864 Cr

P/E ratio

34.8

P/B ratio

29.8

ROCE

108.0%

ROE

26.6%

Dividend yield

2.6%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹2,295.3052-week low ₹1,735.00

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 3.8% over the past year, and 8.3% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales improved from 29.9% to 30.6% over the last four years.

Whether it grew faster than its sector

It grew 8.3% a year against a sector median of 9.9% — 1.6 percentage points slower.

Room to re-rate, or risk of de-rating

At 34.8× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 35.9×, across 5 companies. It is against its own five-year median of 43.6×, the 0th percentile of its own range.

Whether growth justifies the valuation

Priced at 4.3 times its growth rate, on earnings growth of 8%.

Profit growthPrice per ₹1 profitPer 1% growth
Colgate-Palmolive India — this one8%/yr34.8×₹4.3
Godrej Consumer Products5%/yr42.5×₹8.5
Dabur India4%/yr33.6×₹8.4
Cupid Limited—348.8×—
Gillette India Limited31%/yr35.9×₹1.2
Procter & Gamble Hygiene and Health Care Limited14%/yr27.8×₹2.0

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Personal Care), it ranks 2 of 10 on returns, 8 of 10 on growth, 2 of 10 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

A wide advantage: it earns 108% on capital, ahead of 80% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹7201 crore of cash from the business, spent ₹342 crore on plant and equipment, and returned ₹6466 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 112 arrived as cash (before interest, which is why it can exceed the profit). Its cash comes back faster than it used to: it went from being paid 25 days before it paid its own suppliers to paid 59 days before it paid its own suppliers.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

9 of 9 checks clear · 100%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Sales of 1,603 crore rupees and net profit of 343 crore rupees, with the small price rise promised in May still to reach shops.

Announced 29 Jul 2026 · Standalone

Revenue

₹1,603 Cr

Net profit

₹343 Cr

Net margin

21.4%

EPS

₹12.61

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹46,864 Cr
Prev close
₹1,735.70
52w High
₹2,330
52w Low
₹1,716
Enterprise value
₹47,547 Cr
Beta
0.8
Price CAGR 1y
-19.0%
Price CAGR 3y
-3.0%
Price CAGR 5y
1.0%
Price CAGR 10y
6.0%

Ratios

Return on assets
38.9%
PEG ratio
4.3
P/E ratio
34.8
P/B ratio
29.8
EV / EBITDA
25.4
Industry P/E
34.7
ROCE
108.0%
ROCE 5y average
96.2%
ROE
26.6%
Debt / Equity
0.0
Interest coverage
447.0
Dividend yield
2.6%
ROE 3y average
79.0%
ROE last year
83.0%

Annual P&L

Annual revenue
₹6,035 Cr
Annual profit
₹1,325 Cr
Operating margin
31.0%
Net profit margin
22.0%
EBITDA margin
31.0%
Sales growth 3y
4.9%
Sales growth 5y
4.5%
Profit growth 3y
8.0%
Profit growth 5y
5.0%
EPS
₹48.7
Sales growth TTM
4.0%
Profit growth TTM
-2.0%
Dividend payout
119.0%

Quarter P&L

Sales latest quarter
₹1,603 Cr
Profit latest quarter
₹343 Cr
YoY quarterly sales growth
11.8%
YoY quarterly profit growth
6.9%
OPM latest quarter
30.1%

Balance Sheet

Book Value
₹58.7
Face Value
₹1.0
Total debt
₹47 Cr
Total cash
₹1,469 Cr
Borrowings
₹47 Cr
Reserves / Equity
57.7

Cash Flow

Operating cash flow
₹1,806 Cr
Free cash flow
₹1,730 Cr
FCF yield
3.7%
Net cash flow
₹758 Cr

Shareholding

Promoter holding
51.0%
FII holding
13.6%
DII holding
15.5%
Public holding
19.6%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Godrej Consumer872.5043.089,2512.29504.510.64,225.515.418.8
Dabur India388.9034.869,1082.12586.215.03,764.410.620.3
Colgate-Palmoliv1,809.4036.249,5062.65343.17.81,603.311.8108.0
Cupid324.20317.443,6080.0044.2194.0157.0142.533.9
Gillette India7,057.0034.422,9622.55159.59.4783.010.890.7
P & G Hygiene6,865.0028.222,2963.35126.3-34.3891.5-4.9157.2
Emami384.0022.216,7902.60138.9-16.41,039.214.928.1
Median454.4038.616,1970.3490.515.0756.015.430.2

Competes with: Bajaj Consumer Care Limited, Cupid Limited, Dabur India, Emami Limited, Gillette India Limited, Godrej Consumer Products, Honasa Consumer Limited, JHS Svendgaard Laboratories Limited, Procter & Gamble Hygiene and Health Care Limited

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Standalone · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,3241,4711,3961,4901,4971,6191,4621,4631,4341,5201,4861,5951,603
Expenses9069899279589881,1221,0079649811,0541,0441,0861,120
Material Cost386346394372427433
Change in Inventories-2260-14-0.08-23-41
Purchases of Stock-in-Trade654084747790
Employee Cost107118118118121129
Other Expenses427418472480484510
Operating Profit418482468532508497454498453465442510483
OPM %32333436343131343231303230
Other Income-521182323762019181531019
Exceptional items (within Other Income)000-8.39-17-3.34
Interest1121111111111
Depreciation44444142424241383837363539
Profit before tax369458443511489530433478432442436474462
Tax %26262626262625262626262526
Net Profit274340330380364395323355321328324353343
EPS in Rs10131214131512131212121313
Diluted EPS in Rs131212121313

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Standalone · to 31 Mar 2026
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3,9823,8683,9824,1884,4624,5254,8415,1005,2265,6806,0406,0356,204
Expenses3,1592,9293,0383,0743,2263,3233,3313,5343,6793,7794,0824,1654,304
Material Cost1,5791,538
Change in Inventories-7123
Purchases of Stock-in-Trade310276
Employee Cost447475
Other Expenses1,8171,853
Operating Profit8239409441,1141,2361,2021,5101,5661,5471,9011,9581,8701,900
OPM %21242427282731313033323131
Other Income32741266849302642571396466
Exceptional items (within Other Income)0-25
Interest0000210765543.794
Depreciation75111133157159198182177175172163146148
Profit before tax7808358519831,1431,0431,3501,4091,4101,7811,9301,7841,814
Tax %283032323222232326262626
Net Profit5595815776737768161,0351,0781,0471,3241,4371,3251,348
EPS in Rs21212125293038403949534950
Diluted EPS in Rs5349
Dividend Payout %58474797819310010110111997119

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
5%
5 years
5%
3 years
5%
TTM
4%

Compounded profit growth

10 years
8%
5 years
5%
3 years
8%
TTM
-2%

Stock price CAGR

10 years
6%
5 years
1%
3 years
-3%
1 year
-19%

Return on equity

10 years
66%
5 years
75%
3 years
79%
Last year
83%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Standalone
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital142727272727272727272727
Reserves7571,0041,2471,4971,4201,5671,1391,7071,6891,8471,6371,557
Borrowings000083102918369726147
Other Liabilities9329721,0371,0391,0979081,6371,0841,0981,2501,2931,777
Total Liabilities1,7022,0032,3112,5642,6262,6042,8942,9022,8833,1973,0193,408
Fixed Assets7821,0081,1081,1461,1911,1231,065963862794776718
CWIP141781671591991901451221141103827
Investments3731313131191900000
Other Assets7428851,0051,2281,2061,2721,6661,8171,9072,2922,2042,663
Total Assets1,7022,0032,3112,5642,6262,6042,8942,9022,8833,1973,0193,408

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Standalone
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity6386896886949839307841,6261,1761,1991,3941,806
Cash from Investing Activity-272-237-342-207-96-1971-108-87956374
Cash from Financing Activity-385-391-341-380-815-891-956-1,091-1,087-1,195-1,671-1,422
Net Cash Flow-186151077320-1014278283-221758
Free Cash Flow3394173674858798697271,5761,1071,1231,3231,730

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Standalone
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days6101218171191611111413
Inventory Days637272565869797868637675
Days Payable128136148152144142179169155187185275
Cash Conversion Cycle-59-55-63-79-68-63-91-75-76-113-95-188
Working Capital Days-40-43-39-33-36-23-84-25-32-46-37-59
ROCE %114967471736592927997105108

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Standalone · to 30 Jun 2026
Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters515151515151515151515151
FIIs242525242524222017151414
DIIs5.595.605.825.725.556.577.849.3412141516
Government0.280.280.280.280.280.280.280.280.280.280.280.28
Public191918191818191920202020
No. of Shareholders2,37,9072,38,2002,31,0612,48,8012,39,1932,65,3372,82,9733,05,2223,32,4093,37,6083,33,7413,26,817

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year -21.4% (₹2,208.60 → ₹1,735.70)Brick size ₹43.80 (fixed)Bricks 39
₹1,800₹2,000₹2,200₹1,736Nov '25Jan '26Mar '26May '26Jul '26Sep '26
Price moved up one brickPrice moved down one brickLast close ₹1,735.70 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

FY revenue / permanent employees + workers, same basis (calc)

2,65,15,817inr

2026-03-31

News

News and filings about Colgate-Palmolive India. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Uses as raw material

  • Carton board / paper packaging
  • Palm oil derivatives / oleochemicals (surfactants, soap base)
  • Plastic packaging (laminate tubes, HDPE/PP bottles & caps)
  • Silica, calcium carbonate, fluoride & flavours
  • Sorbitol (corn-derived) & humectants

Depends on the price of

  • Crude Oil Brent
  • Palm Oil
  • corn
  • paper_pulp

Buys from

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Fast Moving Consumer Goods
Industry
Personal Care
Classification
Fast Moving Consumer Goods › Personal Care
ISIN
INE259A01022

Plants

  • Baddi plant · Baddi, Himachal Pradesh
  • Kundaim plant · Kundaim, Goa
  • Sanand plant
  • Sri City plant · Sri City / Satyavedu, Andhra Pradesh

News impact

Big market events that reach Colgate-Palmolive India, and how the effect spreads.

Who it hits first

  • Cupid raised its FY27 targets for the second time in two weeks, now guiding Rs 800 crore revenue and Rs 250 crore net profit.
  • Shares hit a fresh 52-week high, extending a 617% one-year run on strong home and export demand.
  • No other company's earnings change: the raise covers Cupid's own orders only.

Who may gain

  • Cupid shareholders, who see higher expected earnings and a fresh 52-week high
  • Cupid distributors and export partners, if higher volumes flow through their channels
  • No peer beneficiary: rival consumer-goods makers gain no sales from Cupid's own targets

Along the supply chain

Downstream

Distributors and export agents handling Cupid's products move higher volumes as the raised targets turn into shipments.

Upstream

Mild upstream pull: if Cupid makes more goods, its raw-material and packaging suppliers see slightly bigger orders.

Where demand moves

Business

Real product demand: buyers at home and abroad are ordering more of Cupid's goods, which is why its targets rose twice in two weeks.

Capital

Growth money chases the raise, bidding Cupid to a 52-week high; peers see no spillover inflows since their earnings are untouched.

How it spreads across sectors

Fast Moving Consumer Goods

Neutral: large consumer-goods makers share no shelf or tender with Cupid's niche, so no sales spill over.

Healthcare

Positive but narrow: one small company's beat lifts sentiment without changing hospital, lab or pharma demand.

When it plays out

Immediate

Cupid extends gains over 1-7 days as the raise sinks in; peers drift with the market.

Medium term

Over 1-6 months Cupid must convert guidance into quarterly numbers; any miss would unwind the premium fast.

Short term

Over 1-4 weeks Cupid consolidates near highs unless buyers keep chasing; profit-booking risk grows after 617%.

Who it hits first

  • Cupid Limited, a small maker of personal-care and contraceptive goods, jumped 10% to Rs 291 on news that it joins the Nifty Smallcap 250 index from September 30.
  • Joining the index means mutual funds and exchange-traded funds that copy that index (called passive funds) must buy Cupid shares, creating a one-off wave of forced buying.
  • The stock has already surged 250% in six months, and strong June-quarter results plus higher FY27 guidance give buyers a growth story beyond the index news.
  • No factory, order, or sales change is involved — this is purely a money-flow event, not a business event.

Who may gain

  • Cupid's existing shareholders, who gain as forced index buying pushes the share price up.
  • Cupid Limited itself, which gets more visibility and easier future fundraising as an index stock.
  • Short-term traders who bought before the announcement and can sell into the passive demand.

Along the supply chain

Downstream

No direct supply-chain link downstream — distributors and retailers see no change in product flow from a stock-market event.

Upstream

No direct supply-chain link upstream — index inclusion does not change Cupid's raw-material or packaging orders.

Where demand moves

Business

No change in business demand — shops do not order more Cupid products because the stock joined an index; sales depend on the June-quarter momentum and guidance, not the listing.

Capital

Positive capital demand for Cupid only — passive funds that copy the Nifty Smallcap 250 must buy the stock around September 30, and active traders front-running that bid amplified the 10% pre-move.

How it spreads across sectors

Fast Moving Consumer Goods

Neutral for peers — Godrej Consumer, Dabur, Emami, Colgate and other personal-care makers get no order or money-flow spillover from Cupid's inclusion.

Healthcare

Negligible — a single-stock index-flow event with no change in healthcare demand, pricing, or regulation.

When it plays out

Immediate

September 30 inclusion day: forced passive buying, high volume, and a choppy price as pre-positioned traders sell into the index bid.

Medium term

1–6 months: index status stops mattering; only earnings delivery against the raised guidance and the stretched valuation decide the path.

Short term

1–4 weeks: tracking settles, the index premium fades, and the price drifts on profit-taking versus the FY27 guidance story.

29 Sept, 10:17 IST · Market event · high impact

Honasa Consumer Share Price Falls Over 3% On Block Deal Buzz

Early investors plan to sell up to 89 lakh Honasa shares in a block deal, so Honasa shares fell over 3%, hurting current holders while block buyers may get a discount and rivals see no change.

Fast Moving Consumer Goods

Who it hits first

  • Honasa Consumer, which sells Mamaearth beauty and baby-care products, fell over 3% after news that early backers may sell up to 89 lakh shares in one block trade.
  • Peak XV Partners, Sequoia Capital Global Growth Fund III and Redwood Trust are the likely sellers, cashing out part of their early stake.
  • A big sale like this adds many shares for sale at once, so the price dips until new buyers absorb the block.

Who may gain

  • Block-deal buyers, who may pick up Honasa shares at a discount to the market price
  • Short-term traders who sold early on the buzz and can buy back lower after the sale
  • Patient buyers who want Honasa for its brands and get a cheaper entry on the dip

Along the supply chain

Downstream

No downstream change — Nykaa, the beauty retailer that sells Honasa products, sees the same shopper demand; only Honasa's share price moves.

Upstream

No upstream change — software and order-service providers to Honasa see no order change when investors sell shares.

Where demand moves

Business

No change in shop demand — people buy the same Mamaearth creams and shampoos; only share ownership changes hands.

Capital

Selling pressure on Honasa shares — up to 89 lakh shares offered in the block must find new buyers, so the price slips until the block clears.

How it spreads across sectors

Fast Moving Consumer Goods

No real ripple — a single-company share sale does not change soap, cream or shampoo sales for Dabur, Godrej Consumer, Emami or Colgate.

When it plays out

Immediate

In 1-7 days, Honasa stays weak as the 89-lakh-share block hangs over the price and clears.

Medium term

In 1-6 months, price follows business — Mamaearth growth and profits matter, not the old investor exit.

Short term

In 1-4 weeks, shares steady once the block finds buyers and focus returns to sales and margins.

Who it hits first

  • Colgate India: no direct earnings impact; sentiment mildly positive on parent focus

Who may gain

  • Parent shareholders on portfolio premiumization; potential brand buyers

Along the supply chain

Downstream

Indian distributors and retailers see no portfolio change from this global move.

Upstream

No change — Indian sourcing and manufacturing footprint untouched by a US brand sale.

Where demand moves

Business

No demand shifts — Indian toothpaste volumes and pricing continue on domestic drivers.

Capital

FMCG investors note the premiumization theme; no meaningful rotation into COLPAL on this headline.

How it spreads across sectors

Fast Moving Consumer Goods

neutral — global portfolio move with no India earnings read-through

When it plays out

Immediate

COLPAL flat to +1% on sentiment

Medium term

Non-event unless India assets enter the sale perimeter

Short term

Deal contours clarify; no India impact expected

Who it hits first

  • Packaged food makers in the high-sugar, high-salt and high-fat categories - biscuits, snacks, confectionery, instant noodles, soft drinks, dairy desserts - would have to carry a red hexagon warning on the front of pack.
  • Britannia, Nestle India, Varun Beverages and Hatsun Agro are the most directly exposed listed names.
  • This is still a draft open to consultation, not a final order, so nothing changes for at least several quarters.

Who may gain

  • Companies already positioned in health, low-sugar and nutrition variants, which gain a visible shelf advantage over marked competitors.
  • Specialty ingredient and sweetener suppliers, as reformulation demand rises across the industry.
  • Food testing, certification and labelling-compliance service providers.

Along the supply chain

Downstream

Downstream, modern retailers and quick-commerce platforms would have to display the warnings in listings too, and past international experience is that marked products lose shelf prominence. Small kirana retail is less affected because the warning is on the pack rather than the shelf.

Upstream

Reformulation is an upstream event: it pulls demand towards sweetener, fibre, salt-replacement and fat-substitute suppliers and towards flavour houses that can rescue taste after a recipe cut. Packaging and label printers face a mandatory redesign of every affected pack, which is a one-time volume of work for them.

Where demand moves

Business

A warning label does not remove demand for snacking, it redirects it - shoppers shift towards unmarked variants, smaller pack sizes, and fresh or unpackaged alternatives, which is a quiet transfer from organised packaged food towards local unbranded producers who are outside the labelling net. Inside the industry, demand shifts towards reformulated and 'no-warning' variants, pulling orders towards ingredient suppliers who can cut sugar, salt and fat without ruining taste.

Capital

Investors mark down the pure-play high-sugar and high-fat names - biscuits, soft drinks, ice cream - and rotate towards diversified consumer companies where food is a minority of revenue, such as Hindustan Unilever, and towards health-positioned portfolios. Because this is a draft rule, that rotation is slow and reverses quickly if the thresholds are diluted in consultation.

How it spreads across sectors

Consumer Services

Quick-service restaurants face parallel pressure for menu labelling.

Fast Moving Consumer Goods

Volume risk in high-sugar, high-salt and high-fat categories, plus reformulation and repackaging cost.

Healthcare

A public-health-positive measure that supports the diabetes and obesity prevention agenda.

codex additions

When it plays out

Immediate

Minimal. It is a draft, and markets have seen labelling proposals stall before.

Medium term

If it is notified with strict thresholds, expect a genuine reformulation cycle across Indian packaged food over one to two years, with volume pressure concentrated in biscuits, confectionery and sugary drinks.

Short term

Watch the consultation submissions and whether industry succeeds in softening the thresholds - that, not the proposal itself, determines the impact.

Other sectors it reaches

  • {"causal_chain":"Mandatory front-of-pack warning labels would require artwork redesign, plate changes, inventory write-offs and new packaging runs across packaged food SKUs, supporting demand for flexible packaging, cartons and label converters.","direction":"positive","example_tickers":["UFLEX","EPL","TCPLPACK"],"magnitude":"medium","notes":"Benefit depends on implementation timeline and whether brands can exhaust old packaging inventory.","sector":"Packaging \u0026 Label Printing","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"Packaged food companies may reformulate to reduce sugar, salt or fat thresholds, increasing demand for sweeteners, emulsifiers, starches, flavor systems and functional ingredients.","direction":"positive","example_tickers":["TATACHEM","GODREJIND","JUBLINGREA"],"magnitude":"medium","notes":"Reformulation demand is plausible but category-specific; margins may improve for higher-value ingredient suppliers.","sector":"Specialty Ingredients \u0026 Food Additives","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Warning labels on high-sugar foods and beverages could pressure sugar-heavy packaged categories, while also accelerating substitution toward alternative sweeteners and low-calorie formulations.","direction":"mixed","example_tickers":["BALRAMCHIN","TRIVENI","DWARKESH"],"magnitude":"small","notes":"Negative for refined sugar demand from packaged foods, partly offset if companies diversify into ethanol or specialty sweeteners.","sector":"Sugar \u0026 Sweeteners","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Prominent warning labels can alter shelf conversion, search filters and merchandising, shifting demand from HFSS packaged foods toward healthier substitutes and private-label reformulations.","direction":"mixed","example_tickers":["DMART","TRENT","NYKAA"],"magnitude":"small","notes":"Retailers may see mix shifts rather than demand destruction; platforms with health-focused discovery could benefit.","sector":"Organized Food Retail \u0026 Grocery Platforms","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Packaged food brands facing label-driven perception risk may increase spending on repositioning, health claims, packaging communication and campaigns for reformulated products.","direction":"positive","example_tickers":["ZEEL","SUNTV","NAZARA"],"magnitude":"small","notes":"Ad budgets could initially be cautious, but brand repair and relaunch cycles create second-order demand.","sector":"Media, Advertising \u0026 Brand Consulting","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"Dairy desserts, flavored milk and sweetened yogurts may face warning-label risk, while plain dairy, protein-led and low-sugar variants could gain relative share.","direction":"mixed","example_tickers":["HATSUN","HERITGFOOD","DODLA"],"magnitude":"medium","notes":"Impact is more relevant for value-added sweetened portfolios than commodity milk.","sector":"Dairy \u0026 Value-Added Milk Products","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Threshold compliance would require nutrient profiling, lab testing, documentation and supplier audits before label claims and warning status are finalized.","direction":"positive","example_tickers":["SYNGENE","THYROCARE","KRSNAA"],"magnitude":"small","notes":"Pure-play listed food-testing exposure is limited; benefit may accrue to diversified diagnostics, CRO and certification-adjacent businesses.","sector":"Food Testing, Inspection \u0026 Certification","time_horizon":"immediate"}
  • {"causal_chain":"Label redesign, new cartons, new sleeves and compliance-driven packaging changes can lift demand for paperboard, printing inks and packaging substrates.","direction":"positive","example_tickers":["JKPAPER","TNPL","SHREYANS"],"magnitude":"small","notes":"Likely a temporary volume pull-forward unless rules trigger repeated SKU-level redesigns.","sector":"Paper, Inks \u0026 Printing Consumables","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"If reformulation reduces sugar, palm oil or salt intensity and increases grains, millets, nuts, proteins or natural ingredients, upstream crop demand mix may shift.","direction":"mixed","example_tickers":["KAVVERITEL","KSCL","AVANTIFEED"],"magnitude":"small","notes":"Listed exposure is indirect and diffuse; strongest link is through ingredient substitution rather than immediate volume change.","sector":"Agricultural Inputs \u0026 Commodities","time_horizon":"1_to_6_months"}

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

1 Jun 2026interim₹24
3 Nov 2025interim₹24
28 May 2025interim₹27
4 Nov 2024interim₹24
6 Nov 2023interim₹22
19 May 2023interim₹21
31 Oct 2022interim₹18
5 May 2022interim₹21

Splits, bonuses & buybacks

  • daily-prices repair: 9 rows from NSE's archive (replace 1, delete 1, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.